Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic
Albert Garcia‐Romeu, David J. Cox, Kirsten E. Smith, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107849-107849
Open Access | Times Cited: 144

Showing 26-50 of 144 citing articles:

Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.
Oliver Grundmann, Charles A. Veltri, Sara Morcos, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 31, Iss. 5, pp. 963-977
Open Access | Times Cited: 14
Effects of Itraconazole on Pharmacokinetics of Mitragynine and 7-Hydroxymitragynine in Healthy Volunteers
Pooja Mongar, Amit Jaisi, Thammasin Inkviya, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 823-833
Open Access | Times Cited: 5
Mitragynine and Morphine Stabilize Different Conformations of the Μ-Opioid Receptor as Revealed by Molecular Dynamics Simulation Studies
Joydip Das, Jonathan P. Mathews, Netra Prasad Neupane, et al.
(2025)
Closed Access
A proposed screening strategy for evaluating the genotoxicity potential of botanicals and botanical extracts
Kristine L. Witt, Jan van Benthem, Tetyana Kobets, et al.
Food and Chemical Toxicology (2025), pp. 115277-115277
Open Access
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use
Katherine Hill, Jeffrey M. Rogers, Oliver Grundmann, et al.
The American Journal of Drug and Alcohol Abuse (2025), pp. 1-13
Open Access
Effects of kratom alkaloids on mesolimbic dopamine release
James P Manus, Rebecca C Crenshaw, Lindsay C Ringer, et al.
Neuroscience Letters (2025), pp. 138153-138153
Closed Access
Modulatory effects of Kratom extract on the gut microbiota of rats: implications for health
Nattaya Thongsepee, Sumet Amonyingcharoen, Pholasit Chamod, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
Prevalence and Use Patterns of Kratom ( Mitragyna speciosa Korth.) in a US Nationally Representative Sample
Oliver Grundmann, MeShell Green, Erin C. Berthold, et al.
Journal of Psychoactive Drugs (2025), pp. 1-9
Closed Access
Kratom instrumentalization for severe pain self-treatment resulting in addiction – A case report of acute and chronic subjective effects
Elisabeth Müller, Thomas Hillemacher, Christian P. Müller
Heliyon (2020) Vol. 6, Iss. 7, pp. e04507-e04507
Open Access | Times Cited: 33
The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 2, pp. 223-228
Closed Access | Times Cited: 27
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
Forensic Implications of Kratom: Kratom Toxicity, Correlation with Mitragynine Concentrations, and Polypharmacy
Donna M Papsun, William Schroeder, Justin O. Brower, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 272-281
Closed Access | Times Cited: 12
Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
Rita Tabanelli, Simone Brogi, Vincenzo Calderone
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10888-10888
Open Access | Times Cited: 11
Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects
Pietro Brunetti, Alfredo Fabrizio Lo Faro, Anastasio Tini, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 309-309
Open Access | Times Cited: 27
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample
Jeffrey M. Rogers, Kirsten E. Smith, Justin C. Strickland, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review
Catherine W. Striley, Carolin C. Hoeflich, Andrew T Viegas, et al.
Substance Abuse Research and Treatment (2022) Vol. 16
Open Access | Times Cited: 16
Kratom’s Emergence and Persistence Within the US Polydrug Epidemic
Kirsten E. Smith, Jeffrey M. Rogers, Jeffrey D. Feldman
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 262-271
Open Access | Times Cited: 10
Novel methods for the remote investigation of emerging substances: Application to kratom.
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 32, Iss. 2, pp. 215-227
Open Access | Times Cited: 10
Cannabidiol and mitragynine exhibit differential interactive effects in the attenuation of paclitaxel-induced mechanical allodynia, acute antinociception, and schedule-controlled responding in mice
Yuma T. Ortiz, Joshua A. Bilbrey, Jasmine S. Felix, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 937-950
Closed Access | Times Cited: 10
Diagnostic Ambiguities and Underuse of Clinical Assessment Tools: A Systematic Review of Case Reports on Kratom Addiction and Physical Dependence
Kirsten E. Smith, Jeffrey D. Feldman, Destiny Schriefer, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 282-292
Closed Access | Times Cited: 9
Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects
Oliver Grundmann, Katherine Hill, Everest Al Barzanji, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116779-116779
Closed Access | Times Cited: 9
Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving Study
C. Austin Zamarripa, Tory R. Spindle, Leigh V. Panlilio, et al.
Traffic Injury Prevention (2024) Vol. 25, Iss. 4, pp. 594-603
Open Access | Times Cited: 3
Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report
Oliver Grundmann, Kirsten E Smith, Walter C. Prozialeck, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3

Scroll to top